Electroporation therapy of solid tumors

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 16, Issue 6, 1999, Pages 523-569

  Hofmann, G A ^a   Dev, S B ^a   Nanda, G S ^a   Rabussay, D ^a  

^a Inovio Biomedical Corporation   (United States)

Author keywords

Bleomycin; Cancer therapy; Electrochemotherapy; Electroporation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOMYCIN C; VINCRISTINE;

CANCER THERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG TRANSPORT; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; ELECTROPORATION; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; PULSE GENERATOR; REVIEW; SIDE EFFECT; SOLID TUMOR;

EID: 0033389688     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v16.i6.10     Document Type: Review

References (112)

1. Sale, A.J.H. and Hamilton, W.A., Effects of electric fields on microorganisms, I. Killing of bacteria and yeasts, Biochim. Biophys. Acta, 118, 781, 1967.
2. Sale, A.J.H. and Hamilton, W.A., Effects of high electric fields on microorganisms, III. Lysis of erythrocytes and proton plasts, Biochim. Biophys. Acta, 163, 37, 1968.
3. Neumann, E. and Rosenheck, K., Permeability changes induced by electrical pulses in vesicular membranes, J. Membrane Biol., 10, 279, 1972.
4. Neumann, E. and Rosenheck, K., Potential difference across vesicular membranes, J. Membrane Biol., 14, 194, 1973.
5. Riemann, F., Zimmermann, U., and Pilwat, G., Release and uptake of hemoglobin and ions in red blood cells induced by dielectric breakdown, Biochim. Biophys. Acta, 394, 449, 1975.
6. Weaver, J.C. and Chizmadzhev, Y.A., Theory of electroporation: A review, Bioelectrochem. Bioenerget., 41, 135, 1996.
7. Neumann, E., Sowers, A., and Jordan, C., Eds., Electroporation and Electrofusion in Cell Biology, New York: Plenum Press, 1989.
8. Chang, D. C., Chassy, B. M., Saunders, J. A., and Sowers., A. E., Guide to Electroporation and Electrofusion, San Diego: Academic Press, 1992.
9. Zimmermann, U. and Neil, G.A., Electromanipulation of Cells, Boca Raton, FL: CRC Press, 1995.
10. Nickoloff, J. A., Animal cell electroporation and electrofusion protocols, Methods in Molecular Biology, Humana Press, 1995.
11. Kinosita, K. and Tsong, T.Y., Voltage induced formation and hemolysis of human erythocytes, Biochim. Biophys. Acta, 471, 227, 1979.
12. Teissie, J. and Rols, M.P., Fusion of mammalian cells in culture is obtained by creating the contact between cells after their electropermeabilization, Biochem. Biophys. Res. Commun., 140, 258, 1986.
13. Schwister, K. and Deutike, B., Formation and properties of aqueous leaks induced in human erythrocytes by electrical breakdown, Biochim. Biophys. Acta, 816, 332, 1985.
14. Hofmann, G. A. and Evans, G., Electronic Genetic - Physical and Biological Aspects of Cellular Electromanipulation, IEEE Eng. Med. Biol., 5(4), 6, 1986.
15. Nanda, G. S. and Mishra, K. P., Studies on electroporation of thermally and chemically treated human erythrocytes, Bioelectrochem. Bioenerget., 34, 129, 1994.
16. Kinosita, K. and Tsong, T.Y., Formation and resealing of pores of controlled sizes in human erythrocyte membrane, Nature, 268, 438, 1977.
17. Sowers, A. E., The long lived fusogenic state induced in erythrocyte ghosts by electrical pulses is not mobile, Biophys. J., 52, 1015, 1987.
18. Neumann, E., Kakorin, S., and Toensign, K., Fundamentals of electroporative delivery of drugs and genes, Bioelectrochem. Bioenerget., 48(1), 3, 1999.
19. Auer, D., Bradner, G., and Bodemer, W., Dielectric breakdown of red blood cell membrane and uptake of SV 40 DNA and mammalian cell RNA, Naturwissenschaften, 63, 391, 1976.
20. Neumann, E., Schaefer-Ridder, M., Wang, Y., and Hofschneider, P. H., Gene transfer into mouse lyoma cells by electroporation in high electric fields, EMBO Journal, 1, 841, 1982.
21. Banga, A. K., Electrically Assisted Transdermal and Topical Drug Delivery, Bristol, Pennsylvania, USA & Basingstoke, Hants, UK: Taylor and Francis, 1998.
22. Tsong, T.Y. and Kinosita, K., Use of voltage pulses for the pore opening and drug loading, and the subsequent resealing of red blood cells, Bibl. Haematol., 51, 108, 1985.
23. Dev, S.B. and Hofmann, G.A., Electrochemotherapy - a novel method of cancer treatment, Cancer Treat. Rev., 20, 105, 1994.
24. Okino, M. and Mohri, H., Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors, Jpn. J. Cancer Res., 78, 1319, 1987.
25. Nishi, T., Dev, S. B., Yoshizato, K., Kuratsu, J., and Ushio, Y., Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes, Hum. Cell., 10(1), 81, 1997.
26. Aihara, H. and Miyazaki, J., Gene transfer into muscle by electroporation in vivo, Nat. Biotechnol., 16(9), 867, 1998.
27. Nanda, G. S., Sun, F. X., Hofmann, G. A., Hoffman, R. M., and Dev, S. B., Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice, Anticancer Res., 18, 999, 1998.
28. Belehradek, J. J., Orlowski, S., Poddevin, B., Paoletti, C., and Mir, L. M., Electrochemotherapy of spontaneous mammary tumors in mice, Eur. J. Cancer, 27, 73, 1991.
29. Mir, L. M., Banoun, H., and Paoletti, C., Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol, Exp. Cell Res., 175, 15, 1988.
30. Orlowski, S., Belehradek, J. J., Paoletti, C., and Mir, L. M., Transient electropermeabilization of cells in culture: Increase of the cytotoxicity of anticancer drugs, Biochem. Pharmacol., 37(24), 4727, 1988.
31. Gehl, J., Skovsgaard, T., and Mir, L. M., Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs, Anticancer Drugs, 9(4), 319, 1998.
32. Nanda, G. S., Merlock, R. A., Hofmann, G. A., and Dev, S. B., A novel and effective therapy for prostate cancer, Proc. Am. Assoc. Cancer Res., 39, 472, 1998.
33. Nanda, G. S., Merlock, R. A., Hofmann, G. A., and Dev, S.B., Membrane permeabilization of MCF-7 cells by electrical pulses enhances cytotoxicity of anticancer drugs, Proc. Am. Assoc. Cancer Res., 38, 260, 1997.
34. Kanesada, H., Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma, in vivo, J. Jpn. Soc. Cancer Ther., 25(11), 2640, 1990.
35. Salford, L. G., Persson, B. R. R., Brun, A., Ceberg, C. P., Kongstad, P., and Mir, L. M., New brain tumor therapy combining bleomycin with in vivo electropermeabilization, Biochem. Biophys. Res. Commun., 194(2), 938, 1993.
36. Yamaguchi, O., Irisawa, C., Baba, K., Ogihara, M., Yokota, T., and Shiraiwa, Y., Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor, Tohoku J. Exp. Med., 172, 291, 1994.
37. Jaroszeski, M. J., Gilbert, R. A., Perrott, R., and Heller, R., Enhanced effects of multiple treatment electrochemotherapy, Melanoma Res., 6(6), 427, 1996.
38. Kubota, Y., Nakada, T., Yanai, H., Kakizuki, H., Sasagawa, I., and Watanabe, M., Electropermeabilization in bladder cancer chemotherapy, Cancer Chemother. Pharmacol., 39(1-2), 67, 1996.
39. Dev, S. B., Nanda, G. S., An, Z., Wang, X., Hoffman, R. M., and Hofmann, G. A., Effective electroporalion therapy of human pancreatic tumors implanted in nude mice, Drug Deliv., 4(4), 293, 1997.
40. Heller, R., Jaroszeski, M. J., Perrott, R., Messina, J. L., and Gilbert, R. A., Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy, Melanoma Res., 7, 10, 1997.
41. Jaroszeski, M.J., Gilbert, R. A., and Heller, R., In vivo antitumor effects of electrochemotherapy in a hepatoma model, Biochim. Biophys. Acta, 1334, 15, 1997.
42. Mir, L. M., Devauchelle, P., Quintin-Colonna, F., Delisle, F., Dolinger, S., Fradelizi, D., Belehradek, J.J., and Orlowski, S., First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy, Br. J. Cancer, 76(12), 1617, 1997.
43. Yabushita, H., Yoshikawa, K., Hirata, M., Furuya, H., Hojyoh, T., Fukatsu, H., Noguchi, M., and Nakanishi, M., Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma, Gynecol. Oncol., 65(2), 297, 1997.
44. Hasegawa, H., Kano, M., Hoshi, N., Watanabe, K., Satoh, E., Nakayama, B., and Suzuki, T., An electrochemotherapy model for rat tongue carcinoma, J. Oral Pathol. Med., 27, 249, 1998.
45. Nanda, G. S., Sun, F. X., Hofmann, G. A., Hoffman, R. M., and Dev, S. B, Electroporation enhances therapeutic efficacy of anticancer drugs: Treatment of human pancreatic tumor in animal model, Anticancer Res., 18, 1361, 1998.
46. Chazal, M., Benchimol, D., Baque, P., Pierrefite, V., Milano, G., and Bourgeon, A., Treatment of hepatic metastases of colorectal cancer by electrochemotherapy: An experimental study in the rat, Surg. Today, 124(3), 536, 1998.
47. Kambe, M., Arita, D., Kikuchi, H., Funato, T., Tezuka, F., Gamo, M., Murakawa, Y., and Kanamaru, R., Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation, Tohoku J. Exp. Med., 180(2), 161, 1990.
48. Hyacinthe, M., Jaroszeski, M. J., Dang, V. V., Coppola, D., Karl, R. C., Gilbert, R. A., and Heller, R., Electrically enhanced drug delivery for the treatment of soft tissue sarcoma, Cancer, 85(2), 409, 1999.
49. Kuriyama, S., Kikukawa, M., Mitoro, A., Tsujinoue, H., Nakatani, T., Yamazaki, M., Yoshiji, H., Toyokawa, Y., Yoshikawa, M., and Fukui, H., Antitumor effect of electrochemotherapy on colorectal carcinoma in an orhotopic mouse model, Int. J. Oncol., 14, 321, 1999.
50. Ramirez, L.R., Orlowski, S., Bindoula, G., Dzodic, R., Ardouin, P., Bognel, C., Belehradek, J., Munck, J.-N., and Mir, L. M., Electrochemotherapy on liver tumours in rabbits, Br. J. Cancer, 77(12), 2104, 1998.
51. Mir, L. M., Belehradek, M., Domenge, C., Orlowski, S., Poddevin, B., Belehradek, J. J., Schwaab, G., Luboinski, B., and Paoletti, C., Electrochemotherapy, a novel antitumor treatment: First clinical trial, CR Acad. Sci. Paris, 313(3), 613, 1991.
52. Rudolf, Z., Stabuc, B., Cemazar, M., Miklavcic, D., Vodovnik, L., and Sersa, G., Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients, Radiat. Oncol., 29, 229, 1995.
53. Heller, R., Jaroszeski, M.J., Glass, L. F., Messina, J. L., Rapaport, D. P., DeConti, R. C., Fenske, N. A., Gilbert, R. A., Mir, L. M., and Reintgen, D. S., Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy, Cancer, 77(5), 964, 1996.
54. Glass, L. F., Pepine, M. L., Fenske, N. A., Jaroszeski, M. J., Reintgen, D. S., and Heller, R., Bleomycin-mediated electrochemotherapy of metastatic melanoma, Arch. Dermatol., 132(11), 1353, 1996.
55. Giraud, P., Bachaud, J. M., Teissie, J., and Rols, M. P., Effects of electrochemotherapy on cutaneous metastases of human malignant melanoma, Int. J. Radiat. Oncol. Biolog. Phys., 36(5), 1285, 1996.
56. Panje, W. R., Hier, M. P., Garman, G. R., Harrell, E., Goldman, A., and Bloch, I., Electroporation therapy of head and neck cancer, Ann. Otol. Rhinol. Laryngol., 107(9), 779, 1998.
57. Mir,L. M., Glass, L. F., Sersa, G., Teissie, J., Domenge, C., Miklavcic, D., Jaroszeski, M. J., Orlowski, S., Reintgen, D. S., Rudolf, Z., Belehradek, M., Gilbert, R., Rols, M.-P., Belehradek, J., Jr., Bauchaud, J. M., DeConti, R., Stabuc, B., Cemazar, M., Coninx, P., and Heller, R., Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, Br. J. Cancer, 77(12), 2336, 1998.
58. Daskalov, I., Nudrov, N., and Peycheva, E., Exploring new instrumentation prarmeters for electrochemotherapy, IEEE Eng. Med. Biol., 18(1), 62, 1999.
59. Sersa, G., Stabuc, B., Cemazar, M., Jancar, B., Miklavcic, D., and Rudolf, Z., Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients, Eur. J. Cancer, 34(8), 1213, 1998.
60. Hofmann, G. A., Dev, S. B., and Nanda, G. S., Electrochemotherapy: Transition from laboratory to the clinic, IEEE Eng. Med. Biol., 15(6), 124, 1996.
61. Titomirov, A. V., Sukharev, S., and Kistanova, E., In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA, Biochim. Biophys. Acta, 1088(1):131, 1991.
62. Heller, R., Jaroszeski, M., Atkin, A., Moradpour, D., Gilbert, R., Wands, J., and Nicolau, C., In vivo gene electroinjection and expression in rat liver, FEBS Lett., 389(3), 225, 1996.
63. Mir, L.M., Bureau, M.F., Rangara, R., Schwartz, B., and Scherman, D., Long-term, high-level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle, C. R. Acad. Sci. III, 321(11), 893, 1998.
64. Nishi, T., Yoshizato, K., Yamashiro, S., Takeshima, H., Sato, K., Hamada, K., Kitamura, I., Yoshimura, T., Saya, H., Kuratsu, J., and Ushio, Y., High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation, Cancer Res., 56, 1050, 1996.
65. Mansouri, A., Henle, K. J., and Nagle, W. A., Multidrug resistance: Prospects for clinical management, SAAS Bull. Biochem. Biotechnol., 5, 48, 1992.
66. Cemazar, M., Sersa, G., and Miklavcic, D., Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin, Anticancer Res., 18(6A), 4463, 1998.
67. West, C. M., A potential pitfall in the use of electroporation: Cellular radiosensitization, by pulsed high-voltage electric fields, Int. J. Radiat. Biol, 61(3), 329, 1992.
68. Mishra, K. P., Sharma, H. D., Nanda, G. S., and Singh, B. B, Combined effects of gamma irradiation and electroporation on ascites tumor cells, Prog. Biophys. Mol. Biol., 65, 98, Abstract P-CI-47, 1996.
69. Maccarrone, M., Bladergroen, M. R., Rosato, N., and Finazzi Agro, A. F., Role of lipid peroxidation in electioporation-induced cell permeability, Biochem. Biophys. Res. Commun., 209(2), 417, 1995.
70. Hofmann, G. A., Dev, S. B., Dimmer, S., and Nanda, G. S., Electroporation therapy: A new approach for the treatment of head and neck cancer, IEEE Trans. Biomed. Eng., 46(6), 752, 1999.
71. Crooke, S. T. and Bradner, W. T., Bleomycin, a review, J. Med., 7(5), 333, 1976.
72. Twentyman, P. R., Bleomycin-mode of action with particular reference to the cell cycle. Pharmacol. Ther., 23(3), 417, 1983.
73. Mir, L. M., Tounekti, O., and Orlowski, S., Bleomycin: revival of an old drug, Gen. Pharmacol., 27(5), 745, 1996.
74. Chakrabarti, S., Makrigiorgos, G. M., O'Brien, K., Bump, E., and Kassis, A.I., Measurement of hydroxyl radicals catalyzed in the immediate vicinity of DNA by metal-bleomycin complexes, Free Radic. Biol. Med., 20(6), 777, 1996.
75. Voznesenskii, A. I., Galanova, Y. V., and Archakov, A. I., Covalent binding of bleomycin to concanavalin A and immunoglobulin G enhances the ability of the bleomycin-Fe(II) complex to destroy the erythrocyte membrane, Biomed. Sci., 2(2)147, 1991.
76. Ortiz, L. A., Lasky, J., Hamilton, R. F., Jr., Holian, A., Hoyle, G.W., Banks, W., Peschon, J. J., Brody, A. R., Lungarella, G., and Friedman, M., Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice, Exp. Lung Res., 24(6)721, 1998.
77. Pron G., Belehradek J. J., and Mir L. M., Identification of a plasma membrane protein that specifically binds bleomycin, Biochem. Biophys. Res. Commun., 194(1), 333, 1993.
78. Tounekti, O., Pron, G., Belehradek, J., and Mir, L. M., Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Cancer Res., 53, 5462, 1993.
79. Nelson, W. G. and Kastan, M. B., DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways, Mol. Cell. Biol., 14(3), 1815, 1994.
80. Lazo, J. S. and Sebti, S.M., Bleomycin, Cancer Chemother. Biol. Response Modif., 17, 40, 1997.
81. Micallef, M., Immunoregulatory cytokine production by tumor-bearing rat spleen cells and its modulation by bleomycin, Anticancer Drugs, 4(2), 213, 1993.
82. Slosman, D. O., Costabella, P.M., Roth, M., Werlen, G., and Polla, B.S., Bleomycin primes monocytes-macrophages for superoxide production, Eur. Resp. J., 3(7), 772, 1990.
83. Jain, R. K., Barriers to drug delivery in solid tumors, Sci. Am., 271(1), 58, 1994.
84. Sersa, G., Cemazar, M., and Miklavcic, D., Antitumor effectiveness of electrochemotherapy with cis-Diammmedichloroplatinum(II) in mice, Cancer Res., 55, 3450, 1995.
85. Fröhlich, M., Henke, E., Gens, J., Seela, W., and Franke, W. G., Evaluation of intratumoral bleomycin application in a tumor model and in a clinical pilot study. Deutsche Zeitschrift fur Mund, Kiefer und Gesichts-chirurgie, 14(6), 456, 1990.
86. Engstrom, P. E., Jonsson, A. C., Persson, B. R. R., Strand, S., and Salford, L. G., Enhanced cellular uptake of radiopharmaceuticals with electroporation. Application with 111In-oxine, Tumor Target., 2, 251, 1996
87. Belehradek, J. J., Orlowski, S., Ramirez, L. H., Pron, G., Poddevin, B., and Mir L. M., Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin, Biochim. Biophys. Acta, 1190, 155, 1994.
88. Mir, L. M., Bureau, M. F., Ivanov, M-A., Gehl, J., Bettan, M., Rangara, R., Schwartz, B., and Scherman, D., High-level gene expression after electric pulse-mediated gene transfer into skeletal muscle and tumors, Proc. Nat. Acad. Sci. USA, 96, 4262, 1999.
89. Domenge, C., Orlowski, S., Luboinski, B., DeBaere, T., Schwaab, G., Belehradek, J., and Mir L.M., Antitumor electrochemotherapy: New advances in the clinical protocol, Cancer, 77(5), 956, 1996.
90. Sersa, G., Cemazar, M., Semrov, D., and Miklavcic, D., Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice, Bioelectrochem. Bioenerget., 39(1), 61, 1996.
91. Gilbert, R. A., Jaroszeski, M. J., and Heller, R., Novel electrode designs for electrochemotherapy, Biochim. Biophys. Acta, 1334(1), 9, 1997.
92. Melvik, J. E., Pettersen, E. O., Gordon, P. B., and Seglen, P. O., Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells, Eur. J. Cancer Clin. Oncol., 22, 1523, 1986.
93. Okino, M., Tomie, H., Kanesada, H., Maramuto, M., Esato, K., and Suzuki, H., Optimal electric conditions in electrical impulse chemotherapy, Jpn. J. Cancer Res., 83, 1095, 1992.
94. Mir, L. M., Orlowski, S., Poddevin, B., and Belehradek J. J., Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses, Eur. Cytokine Netw., 3(3), 331, 1992.
95. Mir, L. M., Roth, C., Orlowski, S., Belehradek, J. J., Fradelizi, D., Paoletti, C., and Kourilsky, P., Potentiation of the antitumoural effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin 2, CR Acad. Sci. Paris, III, 314, 539, 1992.
96. Tada, T., Matsumoto, K., and Suzuki, H., Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice, Surg. Today, 27, 506, 1997.
97. Cemazar, M., Miklavcic, D., Vodovnik, L., Jarm, T., Rudolf, Z., Stabuc, B., Cufer, T., and Sersa G., Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice, Radiat. Oncol., 29, 121, 1995.
98. Goldfarb, P., Biel, M., Hanna, E., Houck, J., Klotch, D., Nathan, C., Panje, W., Tobbins, T., Shaw, G., El-Sayed, S., Hier, M., Jones, V., Nasser, and J., Rice, A Phase II study using electroporation (EPT) and intratumoral bleomycin in patients with recurrent head and neck cancer: A safe and active treatment approach, Proc. Am. Soc. Clin. Oncol., 18, 397, Abstract 1535, 1999.
99. Bernstein, E. F., Sullivan, F. J., Mitchell, J. B., Salomon, G. D., and Glatstein, E., Biology of chronic radiation effect on tissues and wound healing, Clin. Plast. Surg., 20(3), 435, 1993.
100. Belehradek, M., Domenge, C., Luboinski, B., Orlowski, S., Belehradek, J., and Mir, L. M., Electrochemotherapy, a new antitumor treatment, Cancer, 72(12), 3694, 1993.
101. Sersa, G., Kotnik, V., Cemazar, M., Miklavcic, D., and Kotnik, A., Electrochemotherapy with bleomycin in SA-I tumor-bearing mice - natural resistance and immune responsiveness, Anticancer Drugs, 7, 785, 1996.
102. Sersa, G., Cemazar, M., Menart, V., Gaberc-Porekar, V., and Miklavcic, D., Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice, Cancer Lett., 116(1), 85, 1997.
103. Orlowski, S., An, D., Belehradek, J., and Mir, L. M., Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor, Anticancer Drugs, 9(6), 551, 1998.
104. Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., and Sobol, R.E., Eradication of established intracranial rat gliomas by transforming growth factor ß antisense gene therapy, Proc. Nat. Acad. Sc. USA, 93, 2909, 1996.
105. Muramatsu, T., Mizutani, Y., Ohmori, Y., and Okumura, J., Comparison of three non-viral transfection methods for foreign gene expression in early chicken embryos in ovo, Biochem. Biophys. Res. Commun., 230, 375, 1997.
106. Nishi, T., Goto, T., Yoshizato, K., Dev, S. B., Takeshima, H., Kuratsu, J., Hofmann, G., and Ushio, Y., High-efficiency gene transfer into solid tumors using in vivo electroporation, Proc. Am. Assoc. Cancer Res., 39, 59, 1998.
107. Nishi, T., Goto, T., Yoshizato, K., Takeshima, H., Kuratsu, J., and Ushio, Y., High-efficiency gene transfer in solid tumors by in vivo electroporation, Sixth Intl. Conf. Gene Ther. Cancer, San Diego, CA, 4(6), 1997.
108. Mathiesen, I., Electropermeabilization of skeletal muscle enhances gene transfer in vivo, Gene Ther., 6, 508, 1996.
109. Dev, S. B., Nanda, G. S., Austin, M., Bleecher, S., and Hofmann, G.A., Electroporation-mediated drug delivery is highly effective for treatment of solid tumors, Proc. Am. Assoc. Cancer Res., 40, 582, 1999.
110. Jaroszeski, M. J., Coppola, D., Nesmith, G., Heller, L., Gilbert, R., Pottinger, C., Dang, V., Hickey, J., and Heller, R., Electrically mediated delivery of bleomycin for the treatment of rat hepatomas and hamster pancreatic adenocarcinoma, Proc. Am. Assoc. Cancer Res., 40, 582, 1999.
111. Ceberg, C. P., Bran, A., Mir, L. M., Persson, B. R. R., and Salford, L.G., Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo - a new possibility in boron neutron capture therapy, Anticancer Drugs, 5, 453, 1994.
112. Heller, R., Treatment: of cutaneous nodules using electrochemotherapy, J. Fla. Med. Assoc., 82, 147, 1995.